Banque Pictet & Cie Sa Organon & Co. Transaction History

Banque Pictet & Cie Sa

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$16.59 - $23.77 $606,248 - $868,627	-36,543 Reduced 69.9%	15,738 $273,000
Q2 2023 Aug 04, 2023	BUY	$19.27 - $24.63 $52,761 - $67,436	2,738 Added 5.53%	52,281 $1.09 Million
Q1 2023 May 01, 2023	SELL	$21.42 - $32.08 $348,567 - $522,037	-16,273 Reduced 24.72%	49,543 $1.17 Million
Q4 2022 Feb 06, 2023	BUY	$23.31 - $28.61 $1.53 Million - $1.88 Million	65,816 New	65,816 $0
Q2 2022 Aug 08, 2022	BUY	$31.66 - $38.9 $1.61 Million - $1.97 Million	50,725 New	50,725 $1.71 Million
Q3 2021 Nov 10, 2021	SELL	$28.63 - $35.64 $318,336 - $396,281	-11,119 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $316,335 - $422,522	11,119 New	11,119 $336,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

Stay updated on Banque Pictet & Cie Sa with notifications on news.